Polaryx Therapeutics, Inc. Common Stock

Healthcare

NASDAQ:PLYX · NASDAQ Global Market

Market Cap $109.36M Beta 0.00 P/E (TTM) -16.7

$2.32 -0.87%

-$0.02 today

52W Low $2.01High $48.91

Vol 0.10M · Avg 0.34M

EPS (TTM) -$0.14Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-93.37%

Period High

$35.00

Period Low

$2.26

Latest

$2.32

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Jade Biosciences, Inc.

NASDAQ:JBIO

$551.66M

Crescent Biopharma, Inc.

NASDAQ:CBIO

$487.18M

Lyell Immunopharma, Inc.

NASDAQ:LYEL

$293.54M

Foghorn Therapeutics Inc.

NASDAQ:FHTX

$242.49M

AN2 Therapeutics, Inc.

NASDAQ:ANTX

$135.37M

Kalaris Therapeutics Inc

NASDAQ:KLRS

$89.77M

Kezar Life Sciences, Inc.

KZR

$53.86M

Pelthos Therapeutics Inc.

PTHS

$17.96M

NextCure, Inc.

NXTC

$5.44M

HCW Biologics Inc.

HCWB

$2.22M

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.